Oral semaglutide (high-dose) · Novo Nordisk
Track your Wegovy Pill doses with Phaze.
Wegovy Pill is the once-daily oral form of Wegovy (semaglutide) from Novo Nordisk. The FDA approved it on December 22, 2025, and the European Commission on July 15, 2026. Phaze gives you a place to track pill timing and fasting windows, log side effects, see Estimated Levels, track protein-first nutrition and labs, and keep it all private, in one app.
Wegovy Pill: approved by the FDA on December 22, 2025, and in the EU on July 15, 2026.
Phaze is a wellness and habit-tracking app. It is not a medical device and does not provide medical advice, diagnosis, or treatment. The FDA approved Wegovy Pill on December 22, 2025; Phaze is a tracking tool, not a source or supplier. Estimated Levels is an illustration of the doses you log yourself, not a measurement, and is for information only. Always follow your healthcare provider's guidance.
Oral semaglutide for weight loss, tracked in one private app.
- Drug class
- Oral semaglutide (high-dose)
- Manufacturer
- Novo Nordisk
- Status
- FDA-approved (Dec 22, 2025)
- Route
- Oral
Pill timing & Estimated Levels
Log when you take Wegovy Pill, get a fasting-window reminder, and see your Estimated Levels curve, drawn from the doses you log yourself. Log a planned dose increase and get dose reminders. Estimated levels are free and not medical advice.
Labs & Scans
Track your lab work across 8 categories, GLP-1, metabolic, lipids, vitamins, kidney, liver, thyroid, and inflammation. Enter values for free, or import a lab document by photo (OCR) on Phaze Pro.
Body Composition (Beta)
Estimate body fat % and muscle mass from a photo, with a confidence level and a typical ±3-5% margin, or import a DEXA scan. Body Composition lives inside Labs & Scans, next to your weight and BMI trends.
Side effects & check-ins
Log nausea, fatigue, or any of 40 side effects with severity, then watch the trends. A daily check-in captures mood, energy, hunger, sleep, and bowel health to surface patterns specific to Wegovy Pill.
Apple Watch & widgets
An Apple Watch app plus Home and Lock Screen widgets and Live Activities keep your rings, dose logging, and daily check-ins a glance away.
Wegovy Pill FAQ
Wegovy Pill is the once-daily oral form of Wegovy (semaglutide), made by Novo Nordisk. The FDA approved it on December 22, 2025. This is general information, not medical advice. Talk to your doctor.
You log when you take your pill, get a fasting-window reminder, and see your Estimated Levels curve drawn from the doses you log yourself. You can log a planned dose increase and set dose reminders. Phaze is a tracking tool, it does not supply, prescribe, or recommend any medication.
Yes. The FDA approved Wegovy Pill (semaglutide tablets) on December 22, 2025, and the European Commission authorized it in the EU on July 15, 2026. Other countries decide through their own regulators, so confirm what is available where you live with your healthcare provider. Phaze does not supply, prescribe, or recommend any medication. This is general information, not medical advice.
Phaze tracks lab work across 8 categories, GLP-1, metabolic, lipids, vitamins, kidney, liver, thyroid, and inflammation. Manual entry is free; importing a lab document by photo is part of Phaze Pro. Which labs you watch is a decision for you and your prescriber. Always discuss results with your doctor.
Phaze is built for life on GLP-1 medications, with Estimated Levels, dose and side-effect tracking, protein-first nutrition, labs, progress photos, and private, on-device storage with AES-256-GCM encryption. It's free to start, and the Estimated Levels chart is free for everyone.
Track your Wegovy Pill doses with Phaze.
Doses, side effects, labs, and meals, in one private app. Free to start.
Phaze is a wellness and habit-tracking app. It is not a medical device and does not provide medical advice, diagnosis, or treatment. The FDA approved Wegovy Pill on December 22, 2025; Phaze is a tracking tool, not a source or supplier. Estimated Levels is an illustration of the doses you log yourself, not a measurement, and is for information only. Always follow your healthcare provider's guidance.